Patents by Inventor Chih-Chi Hu

Chih-Chi Hu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12235136
    Abstract: A control method and a controller related to electromagnetic tracking are provided. In the method, a working position is determined, and the working position is the position at which a magnetic field sensor is located relative to a magnetic field emitter; an electrical characteristic of the magnetic field emitter or the magnetic field sensor is adjusted to a target characteristic corresponding to the working position. In this way, the positioning accuracy may be improved.
    Type: Grant
    Filed: December 6, 2022
    Date of Patent: February 25, 2025
    Assignee: Metal Industries Research & Development Centre
    Inventors: Zong-Hsin Liu, Po-Chi Hu, I-Chiao Tsai, Chih-Chung Lin
  • Patent number: 12202899
    Abstract: An anti-PD-L1 antibody, or an antigen-binding fragment thereof, comprising: a heavy chain variable region comprising the three CDRs with the sequences of SEQ ID NOs: 2-4, 6-8, 10-12, 14-16, or 18-20; and/or a light chain variable region comprising the three CDRs with the sequences of SEQ ID NOs: 22-24, 26-28, 30-32, 34-36, or 38-40, wherein the antibody is a chimeric, humanized, composite, or human antibody.
    Type: Grant
    Filed: July 14, 2019
    Date of Patent: January 21, 2025
    Assignee: Development Center for Biotechnology
    Inventors: Cheng-Chou Yu, Shih-Rang Yang, Tsung-Han Hsieh, Mei-Chi Chan, Shu-Ping Yeh, Chuan-Lung Hsu, Ling-Yueh Hu, Chih-Lun Hsiao
  • Patent number: 11731652
    Abstract: Systems, methods, and non-transitory computer-readable media can determine contextual information associated with an environment including a vehicle and at least one agent for generating a computer simulation based on the environment. One or more behavior constraints for the at least one agent can be determined based on the contextual information. A set of trajectories can be generated based on the one or more behavior constraints. A trajectory can be selected from the set of trajectories based on determining that the trajectory satisfies one or more predetermined criteria. The computer simulation can be generated, wherein the computer simulation includes monitoring driving behavior of the vehicle in response to the vehicle interacting with the at least one agent based on the selected trajectory.
    Type: Grant
    Filed: December 15, 2020
    Date of Patent: August 22, 2023
    Assignee: Woven Planet North America, Inc.
    Inventors: David Andrew Dolben, Chih Chi Hu, Peter Ondruska
  • Publication number: 20220185323
    Abstract: Systems, methods, and non-transitory computer-readable media can determine contextual information associated with an environment including a vehicle and at least one agent for generating a computer simulation based on the environment. One or more behavior constraints for the at least one agent can be determined based on the contextual information. A set of trajectories can be generated based on the one or more behavior constraints. A trajectory can be selected from the set of trajectories based on determining that the trajectory satisfies one or more predetermined criteria. The computer simulation can be generated, wherein the computer simulation includes monitoring driving behavior of the vehicle in response to the vehicle interacting with the at least one agent based on the selected trajectory.
    Type: Application
    Filed: December 15, 2020
    Publication date: June 16, 2022
    Applicant: Woven Planet North America, Inc.
    Inventors: David Andrew Dolben, Chih Chi Hu, Peter Ondruska
  • Publication number: 20210008043
    Abstract: The present invention includes substituted chromenones that are useful to inhibit the IRE1/XBP-1 pathway. In certain embodiments, the compounds of the invention inhibit IRE1's RNase activity. In other embodiments, the compounds of the invention are useful to treat or prevent a cancer that involve activation of the ER stress response. The invention also relates, in certain aspects, to the discovery that secretory IgM (sIgM) can orchestrate an immunosuppressive microenvironment by recruiting myeloid-derived suppressor cells (MDSCs) into different tumor models, such as but not limited to solid tumors (such as but not limited to lung cancer) and tumors that have high levels of secreted IgM. In certain embodiments, sIgM produced by B cells or CLL cells can contribute to the accumulation of MDSCs in a tumor. In other embodiments, inhibition of the IRE1/XBP-1 pathway can ablate, minimize, or reduce MDSC levels in a tumor.
    Type: Application
    Filed: April 1, 2019
    Publication date: January 14, 2021
    Inventors: Chih-Chi Hu, Juan R. Del Valle